Open NebulaBack to home
Back to Resources
October 30, 2026Stocks·Neutral·regulatory

FDA extends Agios' mitapivat PDUFA date for sickle cell disease to February 1, 2027

Agios Pharmaceuticals says the FDA has extended the PDUFA date for mitapivat in sickle cell disease to February 1, 2027.

Detected & updated continuously · Source: Nebula

Story subjects

Agios Pharmaceuticals, Inc.Food and Drug Administration

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula